IRF5 and B-cell chronic lymphocytic leukemia: On the other hand, the discovery of an IRF-5 mutation lacking transactivation activity in ATL and CLL may unveil a clue that the transactivation activity of IRF-5 might play an essential role in its function as a turmor suppressor.